Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Berger

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
Preclinical phase II study of ifosfamide in human tumour xenografts in vivoD P Berger, H H Fiebig, B R Winterhalter, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrowH H Fiebig, D P Berger, K Köpping, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenograftsC C Scholz, D P Berger, B R Winterhalter, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 15, 1993
[Unusual course of anti-basement membrane antibody nephritis]D P Berger, I Zäuner, M J Mihatsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologiesD P Berger, L Herbstritt, W A Dengler, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1996
Monogenetic hypertension and pheochromocytomaH P Neumann, B Bender, I Zäuner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsK Breistøl, H R Hendriks, D P Berger, et al.
Virology|March 8, 2000
Vaccination to treat persistent viral infectionM G von Herrath, D P Berger, D Homann, et al.
Virology|July 16, 1999
Lymphotoxin-beta-deficient mice show defective antiviral immunityD P Berger, D Naniche, M T Crowley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsH R Hendriks, S Langdon, D P Berger, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|January 1, 1990
Preclinical phase II study of ifosfamide in human tumour xenografts in vivoD P Berger, H H Fiebig, B R Winterhalter, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrowH H Fiebig, D P Berger, K Köpping, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenograftsC C Scholz, D P Berger, B R Winterhalter, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 15, 1993
[Unusual course of anti-basement membrane antibody nephritis]D P Berger, I Zäuner, M J Mihatsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologiesD P Berger, L Herbstritt, W A Dengler, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1996
Monogenetic hypertension and pheochromocytomaH P Neumann, B Bender, I Zäuner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsK Breistøl, H R Hendriks, D P Berger, et al.
Virology|March 8, 2000
Vaccination to treat persistent viral infectionM G von Herrath, D P Berger, D Homann, et al.
Virology|July 16, 1999
Lymphotoxin-beta-deficient mice show defective antiviral immunityD P Berger, D Naniche, M T Crowley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsH R Hendriks, S Langdon, D P Berger, et al.
Pageof 4